LGALS3 and diabetic kidney disease: We found that Gal3 plasma concentrations were low in healthy controls and typically ranged from 30–200 ng mL−1 in DKD patients and mice, indicating that the physiological and pathological levels of Gal3 under DKD conditions peak at approximately 200 ng/ml.